Skip to content
Toggle Navigation
Home
About
Our Team
Our Technology
Non-Intrusive Testing
Patented Cell-CT Imaging
AI Powered Detection
News
Patents
Publications
Contact
VisionGate Presents at the World Conference on Lung Cancer for 2020: LuCED® Sputum Test for Assessment of Lung Cancer Risk in COPD Patients: Sensitivity and Specimen Satisfactory Rate
Home
Publications
VisionGate Presents at the World Conference on Lung Cancer for 2020: LuCED® Sputum Test for Assessment of Lung Cancer Risk in COPD Patients: Sensitivity and Specimen Satisfactory Rate
View Poster
Conference Website
Related Posts
WCLC 2026 – LuCED Assay For Detection Of Early-Stage Lung Cancer From Home-Collected Sputum
October 6, 2026
|
0 Comments
AI Discrimination of Adenocarcinoma vs. Squamous Carcinoma in Detecting NSCLC Non-Invasively from Sputum Using Cell-CT Single-Cell Analysis in 3D
January 26, 2026
|
0 Comments
Page load link
Go to Top
